BB20 Blend 20mg
A lyophilised blend containing 10mg BPC-157 and 10mg TB-500. The combination itself has not been evaluated in published studies.
View record and quotationExplore peptides studied in cellular responses, mitochondrial biology and tissue models, including Elamipretide, LL-37 and Thymosin Beta-4. Each record explains the level and scope of the evidence.
Research materials only. Not for human or animal consumption.
A lyophilised blend containing 10mg BPC-157 and 10mg TB-500. The combination itself has not been evaluated in published studies.
View record and quotationA mitochondria targeting tetrapeptide with accelerated FDA approval for a defined Barth syndrome strength endpoint; broader mitochondrial myopathy and heart failure programmes remain investigational or have not met key endpoints.
View record and quotationCopper peptide evidence is mainly mechanistic, cell, animal, topical and cosmetic, and review level.
View record and quotationAn 80mg lyophilised four peptide blend for tissue repair and inflammation research. The combination has not been evaluated in published studies.
View record and quotationA 10mg lyophilised synthetic peptide corresponding to a region of thymosin beta 4. Studied in cell and animal models, with no human trials for this peptide.
View record and quotationResearch is dominated by animal and laboratory soft tissue, gastrointestinal, tendon, ligament, and muscle injury models.
Read research recordAn investigational human cathelicidin studied in topical venous leg ulcer trials and exploratory biomarker work; its broad antimicrobial, immune, regenerative and oncology research remains largely preclinical.
Read research recordResearch includes cell and animal injury models and early human studies.
Read research recordA short thymosin beta 4 fragment listed in tissue biology research. Evidence for full length thymosin beta 4 should be distinguished from evidence for this four residue fragment.
Read research record